Company / Operating Margin
Kiniksa Pharmaceuticals International, plc Operating Margin History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
11.4%
FY2025
5-year range
-441.0% / 11.4%
FY2021-FY2025
Trend
+205.8%
vs FY2024
Sector context
#40 of 135
Health Care
What the data says
Operating Margin changed +206% YoY in FY2025, a notable deviation from the 4-year average annual change of -5%.
Based on SEC 10-K filings.
11.4% in FY2025 with a 3-year CAGR of +7.0%.
Improved from -9.3% to 11.4% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +7.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#40 of 135 in Health CareTop 30% of 135This company 11.4% Sector average -774.4%
▼
+101.5% above sector average
Key checks
Key Insights
- In FY2025, operating margin increased 205.8% year-over-year.
- Currently 785.8pp above the Health Care sector average.
- Lowest operating margin in the period was in FY2021.
Company context
Key Data Points
- Negative profit margin: -10.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 11.4% | +205.8% |
| FY2024 | -10.8% | -15.7% |
| FY2023 | -9.3% | -309.9% |
| FY2022 | 4.4% | +101.0% |
| FY2021 | -441.0% | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026